Stockscreener 앱 받기
0.00
100.00%
-1.74
전일 마감가:
$1.74
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$45.77M
수익:
$4.99M
순이익/손실:
$-28.29M
주가수익비율:
0.00
EPS:
-1.0528
순현금흐름:
$-36.20M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$2.00
Lava Therapeutics Nv Stock (LVTX) Company Profile
명칭
Lava Therapeutics Nv
전화
31 6 3000 3035
주소
YALELAAN 62, UTRECHT
LVTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
0.00 | 45.77M | 4.99M | -28.29M | -36.20M | -1.0528 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-12 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-12-11 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-10-25 | 개시 | H.C. Wainwright | Buy |
| 2021-04-19 | 개시 | JP Morgan | Overweight |
| 2021-04-19 | 개시 | Jefferies | Buy |
| 2021-04-19 | 개시 | SVB Leerink | Outperform |
모두보기
Lava Therapeutics Nv 주식(LVTX)의 최신 뉴스
What analysts say about LAVA Therapeutics NV 4PKB stockTechnical Breakout Signals & Affordable Trading Growth - earlytimes.in
LAVA Therapeutics NV Financial Disclosures & Filings - TradingView
XOMA Royalty completes acquisition of LAVA Therapeutics By Investing.com - Investing.com Nigeria
Lava Therapeutics shares delisted from Nasdaq following completion of acquisition - Investing.com Nigeria
Lava Therapeutics shares delisted from Nasdaq following completion of acquisition By Investing.com - Investing.com South Africa
XOMA Completes Acquisition of LAVA Therapeutics - TipRanks
[SC TO-T/A] LAVA Therapeutics NV Amended Third-Party Tender Offer | LVTX SEC FilingForm SC TO-T/A - Stock Titan
XOMA Royalty completes acquisition of LAVA Therapeutics - Investing.com
LAVA Therapeutics Announces Executive Departures - TradingView
[8-K] LAVA Therapeutics NV Reports Material Event | LVTX SEC FilingForm 8-K - Stock Titan
Xoma Royalty announces closing of transactions to acquire LAVA Therapeutics N.V. - MarketScreener
XOMA Royalty Corporation Completes Acquisition of LAVA Therapeutics N.V. - Quiver Quantitative
XOMA Royalty (Nasdaq: XOMA) completes LAVA deal; investors get $1.04 plus CVR - Stock Titan
Will LAVA Therapeutics N.V. stock benefit from AI adoption2025 Big Picture & Weekly High Return Opportunities - newser.com
What makes LAVA Therapeutics N.V. (4PKB) stock appealing to growth investorsIPO Watch & High Return Stock Watch Alerts - newser.com
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - The Globe and Mail
EBIT per share of LAVA Therapeutics NV – MUN:4PKB - TradingView
LAVA Therapeutics N.V.(NasdaqGS: LVTX) dropped from NASDAQ Composite Index - MarketScreener
How LAVA Therapeutics N.V. (4PKB) stock expands through international markets2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com
How LAVA Therapeutics N.V. (4PKB) stock trades in high volatilityChart Signals & Proven Capital Preservation Tips - newser.com
How LAVA Therapeutics N.V. stock performs during Fed tightening cyclesQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com
Will LAVA Therapeutics N.V. (4PKB) stock outperform small cap peersMarket Performance Report & Verified Stock Trade Ideas - newser.com
LAVA Therapeutics NV (4PKB.MU) Latest Press Releases & Corporate News - Yahoo! Finance Canada
Will LAVA Therapeutics N.V. (4PKB) stock justify high valuationWeekly Profit Report & Expert Curated Trade Setup Alerts - newser.com
Why hedge funds are buying LAVA Therapeutics N.V. stockJuly 2025 Setups & Entry Point Confirmation Signals - newser.com
Advanced analytics toolkit walkthrough for LAVA Therapeutics N.V.Sell Signal & High Yield Stock Recommendations - newser.com
Will LAVA Therapeutics N.V. stock benefit from green energy trendsWall Street Watch & Expert Curated Trade Ideas - newser.com
Can LAVA Therapeutics N.V. (4PKB) stock expand revenue streamsWeekly Investment Report & Technical Confirmation Alerts - newser.com
How to track smart money flows in LAVA Therapeutics N.V.2025 Winners & Losers & Daily Profit Focused Screening - newser.com
Is LAVA Therapeutics N.V. showing signs of accumulationWall Street Watch & Reliable Intraday Trade Alerts - newser.com
How LAVA Therapeutics N.V. stock valuations compare to rivals2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
Why LAVA Therapeutics N.V. (4PKB) stock stays on buy listsWeekly Trade Analysis & Safe Swing Trade Setups - newser.com
Published on: 2025-11-19 00:31:28 - newser.com
Analyzing LAVA Therapeutics N.V. with risk reward ratio chartsPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Custom strategy builders for tracking LAVA Therapeutics N.V.July 2025 Levels & Weekly High Conviction Ideas - newser.com
Lava Therapeutics Nv (LVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lava Therapeutics Nv 주식 (LVTX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 16 '25 |
Sale |
1.49 |
690,239 |
1,028,456 |
4,128,912 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 14 '25 |
Sale |
1.51 |
227,341 |
343,285 |
5,019,151 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 13 '25 |
Sale |
1.54 |
47,686 |
73,436 |
5,246,492 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 10 '25 |
Sale |
1.55 |
49,869 |
77,297 |
5,294,178 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 09 '25 |
Sale |
1.56 |
48,169 |
75,144 |
5,344,047 |
| Cooperatieve Gilde Healthcare | 10% Owner |
Oct 08 '25 |
Sale |
1.57 |
28,954 |
45,458 |
5,392,216 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 19 '25 |
Sale |
1.40 |
2,370,533 |
3,322,065 |
0 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 19 '25 |
Sale |
1.40 |
532,870 |
746,764 |
0 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 17 '25 |
Sale |
1.49 |
362,806 |
540,291 |
2,736,644 |
| Versant Venture Capital VI, L. | 10% Owner |
Sep 18 '25 |
Sale |
1.44 |
366,111 |
527,859 |
2,370,533 |
0.45%
1.13%
자본화:
|
볼륨(24시간):